CagriSema in Clinical Trials: What Patients Should Know Cagrilintide More Biotechnology PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar Cagrilintide and tirzepatide are NOT medically equivalent, and one cannot replace the other like a refill. , Tirzepatide is FDA approved and dosed once weekly with careful titration based on Cagrilintide: What It Is and How It's Being Studied for Weight Loss